Reliable Business Intelligence News About Clinical Laboratories, Pathology Groups, & Laboratory
Diagnostics Since 1995

Subscriber?

Issues Archive

The most complete archive of clinical and pathology lab industry news available, including issues from 1997 to the present.

Volume XXIV No. 6 – April 24, 2017

In this issue:

BEYOND THE NEWS OF FDA CLEARANCE of a digital pathology system, THE DARK REPORT explains the actual impact and practical benefits of digital pathology to real-life pathology groups, such as a smoother workflow and greater profitability. Also, researchers involved in a stunning study showing a diagnostic error rate of 21% for patients referred to the Mayo Clinic explain how lab professionals can improve physicians’ diagnostic accuracy and add value to their work.

View Issue TOC


Volume XXIV No. 5 – April 3, 2017

In this issue:

EVERY LABORATORY IN THE U.S. is watching how CMS is moving, step-by-step, to implement the final rule for private payer lab test price reporting, as mandated by PAMA. In this issue, THE DARK REPORT considers potential reasons for the agency’s recent price test reporting delay, the possibility that CMS is manipulating data to get the results it wants, and the disaster that the entire project could be for thousands of labs and their patients.

View Issue TOC


Volume XXIV No. 4 – March 13, 2017

In this issue:

FOR LAB EXECUTIVES, 2017 is shaping up to be the year of the deal, and THE DARK REPORT is your go-to source for all the inside details of the latest lab acquisitions and laboratory sales. Read in this issue about the financial sustainability of hospital lab outreach programs. What does the future hold for hospital lab administrators and clinical pathologists?

View Issue TOC


Volume XXIV No. 3 – February 21, 2017

In this issue:

THE DARK REPORT is first to report that the coming Medicare Part B fee cuts have begun to affect the projected financial sustainability of community labs and hospital lab outreach programs. In two articles, we cover the recent sale of PeaceHealth Laboratories to Quest Diagnostics and the transaction’s implications for the economic viability of outreach lab businesses in the future. Also, in an exceptional development, the University of Michigan Medical Center Department of Pathology is learning new ways to add value that include face-to-face meetings with patients. And, a first look on the important trend of rising salaries for pathologists and PhDs with expertise in molecular and genetic testing.

View Issue TOC


Volume XXIV No. 2 – January 30, 2017

In this issue:

THE CLASH BETWEEN the benefits versus costs of pharmacogenomics — supposedly the wave of the future because of its role in personalized medicine — is highlighted by two contrasting, in-depth reports in this issue of THE DARK REPORT. One health system successfully leverages it to radically improve patient outcomes, while two others have been slammed with massive recoupment demands on the grounds that such tests are medically unnecessary, as reported first in THE DARK REPORT. Also, THE DARK REPORT steps out at the front of a new movement toward an entirely new lab business model: Clinical Laboratory 2.0.

View Issue TOC


Volume XXIV No. 1 – January 9, 2017

In this issue:

IN A MUST-READ, IN-DEPTH ANALYSIS, THE DARK REPORT reports on a $26 million repayment demand faced by a pioneer in the fields of exome sequencing and pharmacogenomic testing — and just as clinical labs and pathologist have always feared, it comes from an audit by a private auditor under the Medicare Zone Program Integrity Contractor (ZPIC) program. With Chapter 11 bankruptcy facing the company, all laboratorians must understand the power of the auditor going forward, especially if this is a sign that ZPIC audits will be more aggressive in the future.

View Issue TOC


Volume XXIII, No. 17 – December 19, 2016

In this issue:

THE DARK REPORT’S ANNUAL TOP 10 for the year delivers a must-read review of the trends and developments that shook up the clinical laboratory industry, including the flaming collapse of Theranos and the PAMA final rule that promises severe Medicare fee cuts and the potential for labs to simply go out of business. Also, the impending arrival of BeaconLBS in Texas will set up a cutthroat price competition for labs there.

View Issue TOC


Volume XXIII No. 16 – November 28, 2016

In this issue:

THIS ISSUE, THE SECOND SPECIAL ISSUE dedicated to the PAMA Final Rule, delivers expert analysis of the probable impact of coming Medicare cuts, which includes the possible demise of a sizeable number of community labs, rural hospitals, and community hospitals. THE DARK REPORT also has an exclusive examination of the multitude of errors that many reporting labs are almost certain to find in their data, advising on avoiding these issues; discusses the merits of a court challenge to the Final Rule; and gives an update on similar data reporting in California.

View Issue TOC


Volume XXIII No. 15 – November 7, 2016

In this issue:

THIS SPECIAL ISSUE OF THE DARK REPORT delivers the lab industry’s first credible look at the actual private payer lab test price data that four categories of labs will report to CMS under PAMA. This is a DARK REPORT exclusive and gives labs an absolutely critical understanding of the real differences between what private health insurers pay for lab tests and what Medicare Part B CLFS prices are. Included are data showing that private payers pay considerably less than Medicare. What’s more, THE DARK REPORT has calculated that potential CMS fee cuts for 2018 could total $400 million.

View Issue TOC


Volume XXIII No. 14 – October 17, 2016

In this issue:

IT WON’T BE WELCOME NEWS to clinical labs and pathology groups in Texas — and around the country — that UnitedHealthcare will introduce its laboratory benefit management program in the Lone Star State. THE DARK REPORT’s exclusive analysis shows how the move will change the access many labs have to UHC patients and probably reduce the money these labs are paid if and when they do perform testing for UHC patients — and perhaps generate the same opposition that it has in Florida. Also in this issue is a detailed analysis of how clinical labs and pathology groups will need to align their diagnostic services to meet the changing needs of hospitals and providers in order to continue generating revenue.

View Issue TOC


Don’t Be at the Mercy of the Tumultuous Healthcare Revolution

Subscribe to The Dark Report for as little as $15.27 per week.

platinum_edition

Get the most expert business intelligence for clinical laboratories and pathology groups available today. Subscribe to The Dark Report.

CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025

Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.

See the full table of contents

How Much Laboratory Business Intelligence Have You Missed?

Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!

Start My 14 Day Trial
Learn More

Need A Group Membership? Company Discounts are Available!

Get More Information Now!

Sign up for TDR Insider

Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.

Click Here to Sign Up

Topics

Visit The Dark Library
Facebook-f Twitter Linkedin-in

The Dark Report
1000 N West Street, Suite 1200 Wilmington, Delaware, United States, 19801
Phone: 512-264-7103
Email: info@darkreport.com

© 2025 The Dark Report. All rights reserved. Part of the LabX Media Group

;